Results 51 to 60 of about 8,089 (207)

Pulmonary endarterectomy and the cost of patient refusal [PDF]

European Respiratory Journal, 2018
The recommended treatment for operable chronic thromboembolic pulmonary hypertension is pulmonary endarterectomy, and patients who refused surgery in the current study had worse long-term survival than those who underwent surgery http://ow.ly ...
Nick H, Kim, Eckhard, Mayer
openaire   +2 more sources

Decision-making in pulmonary endarterectomy surgery [PDF]

European Respiratory Journal, 2019
Clarification of certain issues related to the UK pulmonary endarterectomy referral pathway, emphasising the importance of referral of all patients with CTEPH to a surgical teamhttp://ow.ly ...
Robin, Condliffe, Syed Rehan, Quadery, David P, Jenkins, Iain J, Armstrong, David G, Kiely   +4 more
openaire   +5 more sources

Reverse right ventricular remodeling after pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension: Utility of magnetic resonance imaging to demonstrate restoration of the right ventricle

, 2006
ObjectivesPulmonary arterial hypertension causes right ventricular remodeling; that is, right ventricular dilatation, hypertrophy, and leftward ventricular septal bowing.
Kloek, Jaap J, Jamieson, Stuart, Reesink, Herre J, J. Tim Marcus, Marcus, J. Tim, Paul Bresser, Tulevski, Igor I, Noordegraaf, Anton Vonk, Bresser, Paul, Herre J. Reesink, Kloek, Jaap J., Igor I. Tulevski, Reesink, Herre J., Vonk Noordegraaf, Anton, Jaap J. Kloek, Stuart Jamieson, Anton Vonk Noordegraaf, Tulevski, Igor I., Marcus, J Tim   +18 more
core   +1 more source

Persistent exercise intolerance after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension

, 2020
AIM: Haemodynamic normalisation is the ultimate goal of pulmonary endarterectomy (PEA) for chronic thromboembolic pulmonary hypertension (CTEPH). However, whether normalisation of haemodynamics translates into normalisation of exercise capacity is ...
Symersky, Petr, Bogaard, Harm-Jan, Vonk Noordegraaf, Anton, Ruigrok, Dieuwertje, Nossent, Esther J, Boonstra, Anco, Braams, Natalia J, van Wezenbeek, Jessie, Meijboom, Lilian J, de Man, Frances S, Marcus, J Tim   +10 more
core   +1 more source

Chronic post-embolic pulmonary hypertension: a new target for medical therapies? [PDF]

European Respiratory Review, 2013
The rationale for the use of pulmonary arterial hypertension-targeted drugs in chronic thromboembolic pulmonary hypertension is based on four bundles of evidence, as follows: 1) the pathobiology of the disease, with a distal component of pre-capillary ...
Marion Delcroix
doaj   +1 more source

Interventional therapies for chronic heart failure: An overview of recent developments

ESC Heart Failure, Volume 12, Issue 2, Page 1081-1094, April 2025.
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo, Si Shi, Yutong Guo, Jie Xiong, Bo Wang, Zengxiang Dong, Dianyu Gao, Yingfeng Tu   +7 more
wiley   +1 more source

Chronic Thromboembolic Pulmonary Hypertension: Medical Treatment [PDF]

, 2013
Chronic thromboembolic pulmonary hypertension (CTEPH) is responsible for significant levels of morbidity and mortality. the estimated cumulative incidence of CTEPH is 2-4% among patients presenting with acute pulmonary thromboembolism.
Savas Ozsu, Halit Cınarka, Özsu, Savaş, Çınarka, Halit   +3 more
core   +1 more source

Impact of Proton Pump Inhibitor Use on Outcomes Following Carotid Artery Stenting for Asymptomatic Carotid Stenosis: A Population‐Based Cohort Study

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Carotid artery stenting (CAS) is an effective treatment for carotid stenosis. Proton‐pump inhibitors (PPIs) are commonly prescribed in the general population. However, the impact of PPI use on outcomes following CAS remains unknown. This study investigated the impact of PPI use on CAS using a retrospective, matched‐cohort analysis from the ...
Chia‐En Wong, Pang‐Shuo Perng, Pei‐Wen Chen, Yu Chang, Chih‐Hao Tien, Jung‐Shun Lee, Liang‐Chao Wang, Chih‐Yuan Huang   +7 more
wiley   +1 more source

Pulmonary artery sarcoma treated with pulmonary endarterectomy and leaflet reconstruction using Ozaki technique

, 2022
Pulmonary arterial intimal sarcomas (PAIS) are rare malignancies with a poor prognosis. Sarcomas present with signs and symptoms mimicking pulmonary thromboembolic disease, delaying the diagnosis. We present a 29-year-old male patient diagnosed with PAIS
AK, KORAY, ÖZTÜRK, FATİH, BOZKURTLAR, EMİNE, ARSAN, SİNAN, YILDIZELİ, BEDRETTİN   +4 more
core   +1 more source

The outcome of reoperative pulmonary endarterectomy surgery [PDF]

Interactive CardioVascular and Thoracic Surgery, 2018
OBJECTIVES: Pulmonary endarterectomy (PEA) is the treatment of choice for patients with chronic thromboembolic pulmonary hypertension (PH). Despite excellent outcomes following PEA, a small proportion of patients have residual proximal disease or present with recurrent chronic thromboembolic PH and may benefit from further surgery.
Ali, Jason M, Dunning, John, Ng, Choo, Tsui, Steven, Cannon, John E, Sheares, Karen K, Taboada, Dolores, Toshner, Mark, Screaton, Nick, Pepke-Zaba, Joanna, Jenkins, David P   +10 more
openaire   +3 more sources